Advanced Search

 

Study ID Status Title Patient Level Data
444563/021 Completed Phase II, double-blind, randomized, placebo-controlled clinical study to assess immunogenicity and reactogenicity of doses of a modified vaccine formulation versus GSK Biologicals’ live attenuated human rotavirus vaccine when orally administered to healthy infants at 2, 4 and 6 months of age Study Listed on ClinicalStudyDataRequest.com
444563/022 Completed A phase II, double-blind, randomized, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of three doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine Study Listed on ClinicalStudyDataRequest.com
444563/023 Completed A placebo-controlled, multi-country & multi-center study to assess the efficacy, safety & immunogenicity of 2 doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants Study Listed on ClinicalStudyDataRequest.com
444563/023(2) Completed A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-centre study to assess the efficacy, safety and immunogenicity of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants.
444563/023(3) Completed A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy, safety and immunogenicity of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants.
444563/024 Completed A multi-country & multi-center study to assess the efficacy, immunogenicity & safety of two doses of GSK Biologicals' oral live attenuated HRV vaccine given concomitantly with routine EPI vaccinations including OPV in healthy infants Study Listed on ClinicalStudyDataRequest.com
444563/028/029/030 Completed A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants Study Listed on ClinicalStudyDataRequest.com
444563/033 Completed Study to assess the clinical consistency of three production lots of GSK Biologicals’ HRV vaccine in terms of immunogenicity and safety when given to healthy infants at 2 and 4 months of age Study Listed on ClinicalStudyDataRequest.com
462795/007 Completed A Two-Period, Randomized, Open-Label, Parallel group, Multiple-Probe Drug Interaction Study to Determine the Effects of NCE on the metabolism of CYP450 Probe Substrates in Healthy Postmenopausal Female Subjects Study Listed on ClinicalStudyDataRequest.com
48 Completed Cardiovascular effects of Bupropion in Depressed Patients with Heart Disease.Extensive searching has revealed that no clinical study report is available for this study.
480848/005 Completed A 28 day, double blind, placebo-controlled, parallel-group dose-ranging phase IIA to examine the safety, tolerability and effects of SB-480848 on LP-PLA2 activity in dyslipidemic patients Study Listed on ClinicalStudyDataRequest.com
480848/010 Completed A multi-centre, randomised, double-blind, placebo-controlled, parallel-group study to investigate the effect of the Lp-PLA2 inhibitor SB-480848 (40, 80mg od) on carotid plaque composition in patients with carotid artery disease and planned carotid endarterectomy, stratified for statin use and gender, after 14+/-4 days treatment Study Listed on ClinicalStudyDataRequest.com
480848/013 Completed A Study to Evaluate the Effect of Steady-State New Chemical Entity (NCE) on the Single-Dose Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Warfarin in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
480848/028 Completed An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects with Moderate Hepatic Impairment Study Listed on ClinicalStudyDataRequest.com
480848/033 Completed A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE). Study Listed on ClinicalStudyDataRequest.com
49 Completed Cardiovascular effects of Bupropion in Depressed Patients with Heart Disease.Extensive searching has revealed that no clinical study report is available for this study.
49563/145 Completed A 26-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Rosiglitazone in Combination with Gliclazide Compared to Normal Upward Titration of Gliclazide in Patients with Type 2 Diabetes Mellitus.
49653/001 Completed Evaluation of the Safety, Tolerablity and Preliminary Pharmacokinetics of Single Rising Doses of BRL 49653C in Normal Volunteers
49653/002 Completed An Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BRL 49653 after 10 Days Repeat Dosing to Obese Subjects
49653/004 Completed Investigation of the Effect of Food on the Pharmacokinetics of BRL 49653C in Healthy Male Volunteers
49653/005 Completed A Single Dose Study to Assess the Safety, Tolerability, Dose Proportionality and Food Effect of the Proposed Commercial Tablet Formulation of BRL 49653C in Healthy Volunteers
49653/006 Completed A 12-Week, Multicenter, Double-Blind, Placebo-Controlled, Dose Response Study Assessing the Safety, Tolerability, and Efficacy of BRL 49653C in Subjects with Non-Insulin Dependent Diabetes Mellitus (NIDDM)
49653/007 Completed An Evaluation of the Pharmacokinetics of a Single Oral Dose of BRL 49653C in Hemodialysis-Dependent Patients with End Stage Renal Disease Compared to Volunteers with Normal Renal Function
49653/008 Completed An Evaluation of the Safety, Tolerability, Pharmacokinetics and Protein Binding of BRL 49653C in Patients with Hepatic Impairment
49653/009 Completed A Multicentre, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Efficacy of Rosiglitazone When Administered to Patients With Type 2 Diabetes Mellitus. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.